23 May 2013
Keywords: fda, advisory, meeting, discuss, safety, biologics, ra
Article | 03 February 2003
The safety of biologic therapies for rheumatoid arthritis which targettumor necrosis factor is to be debated at a US Food ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
10 February 2003
27 January 2003
22 May 2013
© 2013 thepharmaletter.com